CYP3A4 and rhabdomyolysis: Clarithromycin inhibits cytochrome P450 enzyme 3A4 (CYP3A4), which was associated with a doubled risk of hospitalization with rhabdomyolysis or other statin‐related AEs according to a systematic review recently.25